US Pharma & Biotech Neuroscience - PPC Market Share Analysis February 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Neuroscience category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Neuroscience brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data

Share of Clicks - Last month
Domain	Share of clicks
vraylar.com	21.41
rexulti.com	12.9
cvs.com	10.53
caplyta.com	7.42
nurtec.com	6.14
fanapt.com	2.59
migrelief.com	2.31
ziphealth.co	2.07
rexultihcp.com	1.95
walgreens.com	1.72
others	30.96

In the pharmaceuticals PPC landscape, Vraylar.com leads with 21.41% click share, followed by Rexulti.com at 12.9%. CVS.com captures 10.53%, while ‘others’ collectively hold 30.96%.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Neuroscience brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.

See more data

Share of Spend - Last Month
Date	vraylar.com	cvs.com	fanapt.com	nurtec.com	caplyta.com	rexulti.com	briumvi.com	vraylarhcp.com	migrelief.com	ziphealth.co
2025/01/01	42.37%	3.34%	0.01%	4.51%	6.69%	6.07%	0%	0.07%	1.31%	1.43%
2025/01/02	35.45%	8.55%	0%	4.05%	7.78%	0.13%	0.41%	0.03%	3%	1.9%
2025/01/03	35.56%	7.15%	0%	4.14%	8.23%	2.57%	1.86%	0.03%	1.59%	5.55%
2025/01/04	36.92%	5.64%	0%	5.49%	14.86%	3.24%	2.55%	2.61%	2.48%	0.84%
2025/01/05	37.13%	6.89%	0%	7.51%	11.51%	0.01%	4.86%	4.31%	1.77%	0.02%
2025/01/06	24.62%	3.29%	0%	6.51%	4.83%	6.7%	2.65%	0%	1.26%	1.38%
2025/01/07	39.73%	2.5%	0.11%	3.79%	9.15%	6.34%	0.48%	2.59%	1.33%	0.87%
2025/01/08	21.4%	1.55%	3.94%	2.37%	14.26%	5.47%	4.02%	0.06%	1.68%	2.23%
2025/01/09	18.26%	6.62%	4.32%	2.56%	7.64%	11.23%	2.1%	1.88%	2.11%	3.71%
2025/01/10	26.75%	2.02%	2.6%	2.35%	6.2%	5.74%	1.2%	2.49%	2.08%	2.77%
2025/01/11	34.17%	1.59%	2.47%	4.14%	8.86%	2.61%	1.2%	6.08%	3.1%	0.01%
2025/01/12	27.18%	0.83%	1.99%	3.52%	3.27%	8.67%	2.2%	5.96%	4.85%	3.91%
2025/01/13	33.33%	16.49%	3.62%	2.65%	0.73%	2.93%	2.26%	8.87%	0.39%	4.06%
2025/01/14	15.23%	9.87%	4.03%	4.19%	5.72%	15.23%	2.3%	3.65%	2.46%	2.12%
2025/01/15	21.38%	1.55%	3.94%	2.37%	14.25%	5.47%	4.01%	0.06%	1.68%	2.23%
2025/01/16	18.2%	6.6%	4.31%	2.55%	7.61%	11.19%	2.09%	1.88%	2.11%	3.7%
2025/01/21	0%	30.21%	3.36%	12.48%	0%	0.02%	6.69%	0.06%	8.09%	0.05%
2025/01/22	0%	2.45%	18.38%	24.94%	0%	0.04%	11.7%	5.98%	0%	0.08%
2025/01/23	0%	11%	5.43%	7.04%	4.96%	0.16%	1.46%	0%	1.17%	17.52%
2025/01/24	23.69%	4.87%	4.79%	8.91%	7.79%	0.13%	5.68%	2.63%	0.01%	0.01%
2025/01/25	0%	20.87%	12.65%	15.83%	0%	0%	7.85%	0.09%	2.23%	0.85%
2025/01/26	23.79%	17.14%	6.35%	11.46%	7.71%	0%	0.89%	3.23%	2.16%	0%
2025/01/27	25.98%	17.72%	3.67%	6.49%	9.93%	3.56%	3.06%	0%	1.05%	1.82%
2025/01/28	13.37%	15.51%	4.05%	11.71%	5.29%	0%	3.66%	0.07%	1.99%	0%
2025/01/29	13.91%	16.17%	3.44%	5.19%	6.95%	12.62%	3.69%	0%	1.54%	0%
2025/01/30	13.21%	22.23%	5.21%	5.08%	8.35%	4.39%	4.1%	0.04%	0.56%	0.59%
2025/01/31	20.19%	11.09%	7.33%	6.62%	5.41%	3.77%	3.54%	1.88%	1.31%	0.37%

Vraylar.com started January strong, peaking at 42.37% but ended at 20.19%. CVS.com saw fluctuations, peaking mid-month at 30.21%. Fanapt.com and Nurtec.com showed steady growth, while Caplyta.com and Rexulti.com had varied trends. Briumvi.com and Vraylarhcp.com maintained low shares. Migrelief.com and Ziphealth.co had minimal impact.

Market Exposure

Competitor Count for US Pharma & Biotech Neuroscience

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.

See more data

Competitor Count - Last month
Date	Competitor Count
2025/01/01	160
2025/01/02	169
2025/01/03	157
2025/01/04	150
2025/01/05	165
2025/01/06	190
2025/01/07	168
2025/01/08	174
2025/01/09	173
2025/01/10	190
2025/01/11	190
2025/01/12	196
2025/01/13	159
2025/01/14	156
2025/01/15	174
2025/01/16	173
2025/01/21	147
2025/01/22	147
2025/01/23	118
2025/01/24	119
2025/01/25	110
2025/01/26	108
2025/01/27	121
2025/01/28	122
2025/01/29	127
2025/01/30	144
2025/01/31	146

January began with a surge in distinct advertisers, peaking at 196 on the 12th. Mid-month saw fluctuations, but a decline followed, bottoming at 108 on the 26th. The month concluded with a slight recovery, ending at 146.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Neuroscience

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data

Market Loss & Market Gains - Last month
Name	Market Trend
cvs.com	13.43%
nurtec.com	6.29%
fanapt.com	2.85%
walgreens.com	1.37%
walmart.com	1.27%
vraylarhcp.com	-1.4%
rexultihcp.com	-1.47%
caplyta.com	-1.74%
rexulti.com	-8.41%
vraylar.com	-8.8%

In the past month, cvs.com surged with a 13.43% click share increase, while nurtec.com rose by 6.29%. Conversely, vraylar.com and rexulti.com faced declines of 8.8% and 8.41%, respectively.

Campaign Efficiency

US Pharma & Biotech Neuroscience Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data

Date	cvs.com	fanapt.com	vraylar.com	cobenfyhcp.com	migrelief.com	nurtec.com	rexultihcp.com	rexulti.com	caplyta.com	ziphealth.co
2025/01/01	7.79%	0.02%	17.14%	4.72%	3.91%	3.55%	4.63%	4.94%	3.4%	3.43%
2025/01/02	13.2%	0.01%	11.96%	3.04%	7.28%	2.18%	0.13%	0.26%	4.03%	5.15%
2025/01/03	14.73%	0%	13.19%	2.53%	3.48%	2.33%	0%	1.69%	4.62%	8.51%
2025/01/04	13.41%	0.01%	15.88%	0.87%	5.21%	3.84%	2.42%	2.35%	6.81%	1.92%
2025/01/05	16.45%	0%	12.3%	1.97%	5.14%	4.31%	0%	0.01%	4.51%	0.04%
2025/01/06	7.02%	0%	8.2%	3.49%	2.45%	5.49%	6.72%	6.84%	1.96%	1.68%
2025/01/07	4.56%	0.13%	16.32%	4.58%	3.55%	2.87%	6.99%	7%	5.3%	1%
2025/01/08	4.16%	5.69%	6.14%	3.77%	4.24%	1.28%	3.42%	3.48%	6.65%	3.03%
2025/01/09	11.48%	5.17%	6.11%	2.58%	3.62%	1.26%	2.55%	7.66%	3.9%	6.18%
2025/01/10	3.2%	2.87%	7.89%	2.64%	4.45%	1.23%	3.34%	3.38%	3.36%	6.56%
2025/01/11	4.23%	3.48%	13.61%	4.19%	3.86%	2.62%	1.42%	2.03%	5.16%	0.02%
2025/01/12	1.99%	2.29%	8.84%	4.67%	7.37%	1.93%	4.79%	4.82%	1.22%	7.9%
2025/01/13	26.18%	5.35%	11.16%	1.38%	0.39%	1.47%	1.97%	1.87%	1.09%	5.97%
2025/01/14	14.5%	4.41%	4.94%	1.49%	5.32%	1.91%	5.38%	8.07%	1.81%	5.34%
2025/01/15	4.22%	5.77%	6.22%	3.82%	4.29%	1.3%	3.46%	3.53%	6.74%	3.07%
2025/01/16	11.57%	5.21%	6.16%	2.6%	3.65%	1.27%	2.56%	7.71%	3.93%	6.23%
2025/01/21	34.76%	2.94%	0%	1.21%	12.59%	4.3%	0.01%	0.02%	0%	0.04%
2025/01/22	5.25%	24.1%	0%	0.23%	0%	12.92%	0.04%	0.05%	0%	0.1%
2025/01/23	12.88%	6.86%	0%	1.94%	1.53%	3.47%	0%	0.25%	3.22%	12.37%
2025/01/24	9.29%	7.84%	8.69%	5.35%	0.01%	8.38%	0.44%	0.21%	3.19%	0.04%
2025/01/25	30.69%	13.04%	0%	0.11%	3.24%	7.95%	0%	0%	0%	1.22%
2025/01/26	28.4%	8.61%	9.54%	0.15%	4.28%	5.72%	0%	0%	3.5%	0.01%
2025/01/27	27.88%	5.19%	10.6%	0.79%	1.75%	3.33%	2.16%	2.16%	3.89%	2.41%
2025/01/28	22.84%	4.04%	3.74%	0.21%	3.98%	4.32%	0%	0%	1.36%	0.01%
2025/01/29	23.74%	4.67%	4.57%	2.54%	3.47%	3.37%	3.95%	7.67%	2.52%	0%
2025/01/30	31.11%	7.32%	4.26%	2.22%	1.52%	2.59%	1.73%	3.57%	3.13%	1.14%
2025/01/31	18.67%	9.78%	7.83%	3.62%	3.25%	3.22%	2.27%	2.27%	1.91%	0.71%

In January 2025, CVS.com saw fluctuating ad impressions, peaking at 34.76% on the 21st. Fanapt.com surged to 24.1% on the 22nd, while Vraylar.com maintained moderate levels. Cobenfyhcp.com and Migrelief.com had lower shares, with Nurtec.com and Rexulti.com showing sporadic peaks. Caplyta.com and Ziphealth.co had minimal impact. The month ended with CVS.com leading, despite varied trends.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data

1
CAPLYTA® (lumateperone) - How to Ask About CAPLYTA https://www.caplyta.com/download-guide
Rx only. Get the Doctor Discussion Guide to be prepared. See Med Guide & Boxed Warnings. Ask your healthcare provider about CAPLYTA to see if...
2
Medication For Schizophrenia - Treating Schizophrenia? Prescription treatment website
Psychiatrists: Learn About A Prescription Approved To Treat Adults With Schizophrenia. Safety Profile.
3
Suffering From Schizophrenia? - See Treatment Prescription treatment website
Learn about an FDA-approved treatment that may help adult schizophrenia symptoms. Talk to your healthcare provider to see if...
4
Nurtec® ODT (rimegepant) | Orally Disintegrating Tablet https://www.nurtec.com
See stories of real patients that have taken Nurtec ODT. 286+ Million people can get Nurtec ODT through health insurance. See if you're covered. Access resources.
5
VRAYLAR® (cariprazine) - Medication Information https://www.vraylar.com/
See VRAYLAR® (cariprazine) Full Prescribing Information, Including Boxed Warnings. Start the Conversation With Your Healthcare Provider About...

In the competitive landscape of pharmaceuticals, top-performing PPC ads reveal a focus on patient empowerment and education. Caplyta.com emphasizes preparedness with a Doctor Discussion Guide, while cobenfyhcp.com and fanapt.com highlight FDA-approved schizophrenia treatments. Nurtec.com shares patient stories, and vraylar.com encourages proactive healthcare conversations.

Frequently Asked Questions

Data within the PPC Market Share Report 2025 is aggregated every month, highlighting the most significant changes from the previous period.
We use observed data from Google’s search results pages. With 20 million Google SERPs indexed per day. Adthena forms a global index of publicly available searches on Google.

On top of observed data, our data science models and patented technology expand on the insights through estimated metrics like market share, share of spend, and more.

We have 12 years of historical data across industries and our custom-built AI models learn from continuously updated data every day.
The PPC Marketing Share Report is powered by Adthena’s Whole Market View, which is the patented technology that drives value for our 300 enterprise customers.

Our unique approach to search intelligence ingests Google’s Keyword Planner into its learning models, providing a more accurate and up-to-date view of keyword data compared to traditional panel data methods.

With daily data collection and updates, Adthena offers a closer-to-real-time view of the Google Ads auction, enabling timely insights and adjustments.

Adthena focuses specifically on Google Ads, providing a deep dive into the channel and offering detailed insights into its workings. By processing 10 TB of new data daily and employing AI and machine learning models to analyze millions of Google Ads searches per second, Adthena provides a comprehensive and in-depth view of the competitive landscape.

Learn more about our data.

Learn more about our data accuracy
Yes. The PPC Market Share Report 2024 aggregates data from across both device types and Google Shopping.
The PPC Market Share Report 2024 is for enterprise brands and agencies who want quick and high-level, historical benchmarks that are easily digestible and reveal insights, trends and market winners relevant to their own industry.
Our search consultants can introduce you to data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the geographies that need monitoring.

Complete the form below to get started.
Ask Arlo leverages real-time GenAI to answer customers’ questions about their own search data and receive instant, tailored responses and reports directly within the Adthena platform.

With millions of Google SERPs indexed every day, Arlo never misses a trick and makes sure you’re always up to date.

Learn more about Ask Arlo.

Customer Success Stories

the7stars Case Study: Achieving Google Ads PPC Campaign Optimization with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI."Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

US Pharma & Biotech Neuroscience - PPC Market Share Analysis February 2025

Share of Clicks for top 10 US Pharma & Biotech Neuroscience brands

Share of Spend for the top 10 US Pharma & Biotech Neuroscience brands

Competitor Count for US Pharma & Biotech Neuroscience

Market Loss & Market Gains for US Pharma & Biotech Neuroscience

US Pharma & Biotech Neuroscience Share of Impressions

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience

Frequently Asked Questions

Customer Success Stories

the7stars Case Study: Achieving Google Ads PPC Campaign Optimization​ with Adthena

Sage case study: 75% decrease in CPCs with Adthena

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Get the full picture

See this data specific to your brand performance

the7stars Case Study: Achieving Google Ads PPC Campaign Optimization with Adthena